Lipid and polymeric carrier-mediated nucleic acid delivery

Lin Zhu, Ram I. Mahato

Research output: Contribution to journalReview article

80 Citations (Scopus)

Abstract

Importance of the field: Nucleic acids such as plasmid DNA, antisense oligonucleotide, and RNA interference (RNAi) molecules, have a great potential to be used as therapeutics for the treatment of various genetic and acquired diseases. To design a successful nucleic acid delivery system, the pharmacological effect of nucleic acids, the physiological condition of the subjects or sites, and the physicochemical properties of nucleic acid and carriers have to be thoroughly examined. Areas covered in this review: The commonly used lipids, polymers and corresponding delivery systems are reviewed in terms of their characteristics, applications, advantages and limitations. What the reader will gain: This article aims to provide an overview of biological barriers and strategies to overcome these barriers by properly designing effective synthetic carriers for nucleic acid delivery. Take home message: A thorough understanding of biological barriers and the structureactivity relationship of lipid and polymeric carriers is the key for effective nucleic acid therapy.

Original languageEnglish (US)
Pages (from-to)1209-1226
Number of pages18
JournalExpert Opinion on Drug Delivery
Volume7
Issue number10
DOIs
StatePublished - Oct 1 2010

Fingerprint

Nucleic Acids
Lipids
Antisense RNA
Inborn Genetic Diseases
Antisense Oligonucleotides
RNA Interference
Polymers
Plasmids
Pharmacology
DNA
Therapeutics

Keywords

  • Lipid
  • Liposomes
  • Non-viral gene delivery
  • Nucleic acid
  • Oligonucleotides
  • Polymer
  • SiRNA

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Lipid and polymeric carrier-mediated nucleic acid delivery. / Zhu, Lin; Mahato, Ram I.

In: Expert Opinion on Drug Delivery, Vol. 7, No. 10, 01.10.2010, p. 1209-1226.

Research output: Contribution to journalReview article

@article{285269caeb1c4b64beb2b1eeae348740,
title = "Lipid and polymeric carrier-mediated nucleic acid delivery",
abstract = "Importance of the field: Nucleic acids such as plasmid DNA, antisense oligonucleotide, and RNA interference (RNAi) molecules, have a great potential to be used as therapeutics for the treatment of various genetic and acquired diseases. To design a successful nucleic acid delivery system, the pharmacological effect of nucleic acids, the physiological condition of the subjects or sites, and the physicochemical properties of nucleic acid and carriers have to be thoroughly examined. Areas covered in this review: The commonly used lipids, polymers and corresponding delivery systems are reviewed in terms of their characteristics, applications, advantages and limitations. What the reader will gain: This article aims to provide an overview of biological barriers and strategies to overcome these barriers by properly designing effective synthetic carriers for nucleic acid delivery. Take home message: A thorough understanding of biological barriers and the structureactivity relationship of lipid and polymeric carriers is the key for effective nucleic acid therapy.",
keywords = "Lipid, Liposomes, Non-viral gene delivery, Nucleic acid, Oligonucleotides, Polymer, SiRNA",
author = "Lin Zhu and Mahato, {Ram I.}",
year = "2010",
month = "10",
day = "1",
doi = "10.1517/17425247.2010.513969",
language = "English (US)",
volume = "7",
pages = "1209--1226",
journal = "Expert Opinion on Drug Delivery",
issn = "1742-5247",
publisher = "Informa Healthcare",
number = "10",

}

TY - JOUR

T1 - Lipid and polymeric carrier-mediated nucleic acid delivery

AU - Zhu, Lin

AU - Mahato, Ram I.

PY - 2010/10/1

Y1 - 2010/10/1

N2 - Importance of the field: Nucleic acids such as plasmid DNA, antisense oligonucleotide, and RNA interference (RNAi) molecules, have a great potential to be used as therapeutics for the treatment of various genetic and acquired diseases. To design a successful nucleic acid delivery system, the pharmacological effect of nucleic acids, the physiological condition of the subjects or sites, and the physicochemical properties of nucleic acid and carriers have to be thoroughly examined. Areas covered in this review: The commonly used lipids, polymers and corresponding delivery systems are reviewed in terms of their characteristics, applications, advantages and limitations. What the reader will gain: This article aims to provide an overview of biological barriers and strategies to overcome these barriers by properly designing effective synthetic carriers for nucleic acid delivery. Take home message: A thorough understanding of biological barriers and the structureactivity relationship of lipid and polymeric carriers is the key for effective nucleic acid therapy.

AB - Importance of the field: Nucleic acids such as plasmid DNA, antisense oligonucleotide, and RNA interference (RNAi) molecules, have a great potential to be used as therapeutics for the treatment of various genetic and acquired diseases. To design a successful nucleic acid delivery system, the pharmacological effect of nucleic acids, the physiological condition of the subjects or sites, and the physicochemical properties of nucleic acid and carriers have to be thoroughly examined. Areas covered in this review: The commonly used lipids, polymers and corresponding delivery systems are reviewed in terms of their characteristics, applications, advantages and limitations. What the reader will gain: This article aims to provide an overview of biological barriers and strategies to overcome these barriers by properly designing effective synthetic carriers for nucleic acid delivery. Take home message: A thorough understanding of biological barriers and the structureactivity relationship of lipid and polymeric carriers is the key for effective nucleic acid therapy.

KW - Lipid

KW - Liposomes

KW - Non-viral gene delivery

KW - Nucleic acid

KW - Oligonucleotides

KW - Polymer

KW - SiRNA

UR - http://www.scopus.com/inward/record.url?scp=77957032442&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957032442&partnerID=8YFLogxK

U2 - 10.1517/17425247.2010.513969

DO - 10.1517/17425247.2010.513969

M3 - Review article

C2 - 20836625

AN - SCOPUS:77957032442

VL - 7

SP - 1209

EP - 1226

JO - Expert Opinion on Drug Delivery

JF - Expert Opinion on Drug Delivery

SN - 1742-5247

IS - 10

ER -